Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens

Carcinogenesis

Volumn 26, Issue 3, 2005, Pages 689-699

  Iida, Mari ^a,b   Anna, Colleen H ^a   Holliday, Wanda M ^a   Collins, Jennifer B ^a   Cunningham, Michael L ^a   Sills, Robert C ^a   Devereux, Theodora R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Biosafety Research Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; EUGENOL; FRAGILE HISTIDINE TRIAD PROTEIN; METHYLEUGENOL; O NITROTOLUENE; OXAZEPAM; P NITROTOLUENE; PARACETAMOL; TOLUENE DERIVATIVE; UNCLASSIFIED DRUG; 2 NITROTOLUENE; 2-NITROTOLUENE; 4 NITROTOLUENE; 4-NITROTOLUENE; DRUG DERIVATIVE; TOLUENE;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; METABOLISM; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION;

ACETAMINOPHEN; ANIMALS; CARCINOGENS; EUGENOL; FEMALE; GENE EXPRESSION; LIVER; MALE; MICE; NUCLEIC ACID HYBRIDIZATION; OXAZEPAM; POLYMERASE CHAIN REACTION; TOLUENE;

EID: 16244408334     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgi005     Document Type: Article

References (37)

1. National Toxicology Program (2002) Report on Carcinogens, 10th Edn, Carcinogen Profiles 2002. Research Triangle Park, NC.
2. Anna, C.H., Sills, R.C., Foley, J.F., Stockton, P.S., Ton, T.V. and Devereux, T.R. (2000) Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam. Cancer Res., 60, 2864-2868.
3. Anna, C.H., Iida, M., Sills, R.C. and Devereux, T.R. (2003) Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice. Toxicol. Appl. Pharmacol., 190, 135-145.
4. Cherkaoui-Malki, M., Meyer, K., Cao, W.Q., Latruffe, N., Yeldandi, A.V., Rao, M.S., Bradfield, C.A. and Reddy, J.K. (2001) Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis. Gene Expr., 9, 291-304.
5. Christensen, J.G., Romach, E.H., Healy, L.N. et al. (1999) Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice. Carcinogenesis, 20, 1583-1590.
6. Devereux, T.R., Anna, C.H., Foley, J.F., White, C.M., Sills, R.C. and Barrett, J.C. (1999) Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene, 18, 4726-4733.
7. Iida, M., Anna, C.H., Hartis, J. et al. (2003) Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. Carcinogenesis, 24, 757-770.
8. Gonzales, A.J., Christensen, J.G., Preston, R.J., Goldsworthy, T.L., Tlsty, T.D. and Fox, T.R. (1998) Attenuation of G1 checkpoint function by the non-genotoxic carcinogen phenobarbital. Carcinogenesis, 19, 1173-1183.
9. Christensen, J.G., Gonzales, A.J., Cattley, R.C. and Goldsworthy, T.L. (1998) Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens. Cell Growth Differ., 9, 815-825.
10. Devereux, T.R., White, C.M., Sills, R.C., Bucher, J.R., Maronpot, R.R. and Anderson, M.W. (1994) Low frequency of H-ras mutations in hepatocellular adenomas and carcinomas and in hepatoblastomas from B6C3F1 mice exposed to oxazepam in the diet. Carcinogenesis, 15, 1083-1087.
11. NTP (1993) Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies), National Toxicology Program Technical Report Series, Vol. 443. NTP, Research Triangle Park, NC.
12. NTP (2002) Toxicology and Carcinogenesis Studies of o-Nitrotoluene (CAS No. 88-72-2) in F344/N Rats and B6C3F1 Mice (Feed Study), National Toxicology Program Technical Report Series, Vol. 504. NTP, Research Triangle Park, NC.
13. NTP (2002) Toxicology and Carcinogenesis Studies of p-Nitrotoluene (CAS No. 99-99-0) in F344/N Rats and B6C3F1 Mice (Feed Studies), National Toxicology Program Technical Report Series, Vol. 498. NTP, Research Triangle Park, NC.
14. NTP (2000) Toxicology and Carcinogenesis Studies of Methyleugenol (CAS No. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies), National Toxicology Program Technical Report Series, Vol. 491. NTP, Research Triangle Park, NC.
15. Burkey J.L., Sauer, J.M., McQueen, C.A. and Sipes, I.G. (2000) Cytotoxicity and genotoxicity of methyleugenol and related congeners - a mechanism of activation for methyleugenol. Mutat. Res., 453, 25-33.
16. NTP (1993) Toxicology and Carcinogenesis Studies of Acetaminophen (CAS No. 103-90-2) in F344 Rats and B6C3F1 Mice (Feed Studies), National Toxicology Program Technical Report Series, Vol. 394. NTP, Research Triangle Park, NC.
17. Yuen, T., Wurmbach, E., Pfeffer, R.L., Ebersole, B.J. and Sealfon, S.C. (2002) Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res., 30, e48.
18. Ludes-Meyers, J.H., Bednarek, A.K., Popescu, N.C., Bedford, M. and Aldaz, C.M. (2003) WWOX, the common chromosomal fragile site, FRA16D, cancer gene. Cytogenet. Genome Res., 100, 101-110.
19. Ishii, H., Ozawa, K. and Furukawa, Y. (2003) Alteration of the fragile histidine triad gene early in carcinogenesis: an update. J. Exp. Ther. Oncol., 3, 291-296.
20. Pekarsky, Y., Zanesi, N., Palamarchuk, A., Huebner, K. and Croce, C.M. (2002) FHIT: from gene discovery to cancer treatment and prevention. Lancet Oncol., 3, 748-754.
21. Nakashiro, K., Kawamata, H., Hino, S., Uchida, D., Miwa, Y., Hamano, H., Omotehara, F., Yoshida, H. and Sato, M. (1998) Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. Cancer Res., 58, 549-555.
22. Shibanuma, M., Kuroki, T. and Nose, K. (1992) Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor beta 1 and other growth factors. J. Biol. Chem., 267, 10219-10224.
23. Griffin, R.J., Dudley, C.N. and Cunningham, M.L. (1996) Biochemical effects of the mouse hepatocarcinogen oxazepam: similarities to phenobarbital. Fundam. Appl. Toxicol., 29, 147-154.
24. Waxman, D.J. and Azaroff, L. (1992) Phenobarbital induction of cytochrome P-450 gene expression. Biochem. J., 281, 577-592.
25. Dumon, K.R., Ishii, H., Vecchione, A. et al. (2001) Fragile histidine triad expression delays tumor develpment and induces apoptosis in human pancreatic cancer. Cancer Res., 61, 4827-4836.
26. Zanesi, N., Fidanza, V., Fong, L.Y. et al. (2001) The tumor spectrum in FHIT-deficient mice. Proc. Natl Acad. Sci. USA, 98, 10250-10255.
27. Zhao, P., Song, X., Nin, Y., Lu, Y. and Li, X. (2003) Loss of fragile histidine triad protein in human hepatocellular carcinoma. World J. Gastroenterol., 9, 1216-1219.
28. Aqeilan, R.I., Kuroki, T., Pekarsky, Y., Albagha, O., Trapasso, F., Baffa, R., Huebner, K., Edmonds, P. and Croce, C.M. (2004) Loss of WWOX expression in gastric carcinoma. Clin. Cancer Res., 10, 3053-3058.
29. Guler, G., Uner, A., Guler, N., Han, S.Y., Iliopoulos, D., Hauck, W.W., McCue, P. and Huebner, K. (2004) The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Cancer, 100, 1605-1614.
30. Kawamata, H., Nakashiro, K., Uchida, D., Hino, S., Omotehara, F., Yoshida, H. and Sato, M. (1998) Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell. Br. J. Cancer, 77, 71-78.
31. Hanahan, D. and Weinberg, R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
32. Uchida, D., Kawamata, H., Omotehara, F., Miwa, Y., Hino, S., Begum, N.M., Yoshida, H. and Sato, M. (2000) Over-expression of TSC-22 (TGF-beta stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line. Lab. Invest., 80, 955-963.
33. Omotehara, F., Uchida, D., Hino, S., Begum, N.M., Yoshida, H., Sato, M. and Kawamata, H. (2000) In vivo enhancement of chemosensitivity of human salivary gland cancer cells by overexpression of TGF-beta stimulated clone-22. Oncol. Rep., 7, 737-740.
34. Chang, N.S., Doherty, J., Ensign, A., Lewis, J., Heath, J., Schultz, L., Chen, S.T. and Oppermann, U. (2003) Molecular mechanisms underlying WOX1 activation during apoptotic and stress responses. Biochem. Pharmacol., 66, 1347-1354.
35. Yoo, J., Ghiassi, M., Jirmanova, L., Galliet, A.G., Hoffman, B., Fornace, A.J., Jr, Liebermann, D.A., Bottinger, E.P. and Roberts, A.B. (2003) Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation. J. Biol Chem., 278, 43001-43007.
36. Papa, S., Zazzeroni, F., Bubici, C. et al. (2004) Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2. Nature Cell Biol., 6, 146-153.
37. Dunnick, J., Burka, L.T., Mahler, J. and Sills, R. (2003) Carcinogenic potential of o-nitrotoluene and p-nitrotoluene. Toxicology, 183, 221-234.